For the year ending 2025-12-31, FBIOP made $63,262K in revenue. -$1,882K in net income. Net profit margin of -2.97%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Net revenue | 63,262 | |||
| Cost of goods - (excluding amortization of acquired intangible assets) | 20,924 | |||
| Amortization of acquired intangible assets | 4,258 | |||
| Research and development | 11,901 | |||
| Selling, general and administrative | 96,400 | |||
| Total operating expenses | 133,483 | |||
| Loss from operations | -70,221 | |||
| Interest income | 2,485 | |||
| Interest expense and financing fee | 10,106 | |||
| Loss on common stock warrant liabilities | -398 | |||
| Gain from deconsolidation of subsidiary | 27,127 | |||
| Other income | 17,578 | |||
| Total other income (expense) | 36,686 | |||
| Loss before income tax expense | -33,535 | |||
| Income tax expense (benefit) | -620 | |||
| Net loss | -32,915 | |||
| Attributable to non-controlling interests | -39,730 | |||
| Net income (loss) attributable to fortress | 6,815 | |||
| Preferred a dividends declared and paid and/or cumulated, and fortress' share of subsidiary deemed dividends | 8,697 | |||
| Net loss attributable to common stockholders | -1,882 | |||
| Basic EPS | -0.07 | |||
| Diluted EPS | -0.07 | |||
| Basic Average Shares | 27,901,889 | |||
| Diluted Average Shares | 27,901,889 | |||
Fortress Biotech, Inc. (FBIOP)
Fortress Biotech, Inc. (FBIOP)